Cetirizine Hydrochloride
- Product NDC
- 61715-062
- 11-digit product format
- 617150062
- Labeler code
- 61715
- Product ID
- 61715-062_3bc89c6b-418f-47dc-89dd-bddaf5bbcb38
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Cetirizine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Kinray
- Application
- ANDA077498
- Marketing category
- ANDA
- Marketing start
- 2011-12-07
- Marketing end
- 0000-00-00
- Substance
- CETIRIZINE HYDROCHLORIDE
- Active strength
- 10 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61715-062-14 | 2025-05-27 | C162847 | 48780-1 | 9d75b9d0-2302-f424-e053-dadaa90a57ce | 5ecff895-adf3-4bbf-898c-f3bc92ae6f43 |
| 61715-062-30 | 2025-05-27 | C162847 | 48780-1 | 9d75b9d0-2302-f424-e053-dadaa90a57ce | 5ecff895-adf3-4bbf-898c-f3bc92ae6f43 |
| 61715-062-90 | 2025-05-27 | C162847 | 48780-1 | 9d75b9d0-2302-f424-e053-dadaa90a57ce | 5ecff895-adf3-4bbf-898c-f3bc92ae6f43 |
| 61715-062-14 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2302-f424-e053-dadaa90a57ce | 5ecff895-adf3-4bbf-898c-f3bc92ae6f43 |
| 61715-062-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2302-f424-e053-dadaa90a57ce | 5ecff895-adf3-4bbf-898c-f3bc92ae6f43 |
| 61715-062-90 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2302-f424-e053-dadaa90a57ce | 5ecff895-adf3-4bbf-898c-f3bc92ae6f43 |